What Bodycote Doubters Got Wrong

If you only skimmed the headlines about a takeover vote and hedge funds trading Bodycote through derivatives, you might expect a messy outcome for long term holders. Investors who held Bodycote from the start of the year are up 33.5%, including dividends. If you had been deciding on 1 January 2026, with bulls focused on aerospace growth and bears worried about localization and regulation, what really tipped the scales in favour of this result?

The easy part of this move is behind Bodycote. Zero in on 15 high quality undervalued stocks for companies trading below our estimates.

The Two Stories Investors Had To Weigh On Bodycote

The shares cost £6.98 at the start of the period, and anyone looking at Bodycote then had two sharply different stories to work with.

The bullish narrative pointed to a Fair Value of £7.41, a notional price implied by expectations that US aerospace and defence expansion plus Industry 4.0 technologies like HIP would support higher margins and a stronger mix.

The bearish view saw Fair Value at £6.10, based on assumptions that reshoring, tougher regulation and competition would pressure revenue even if efficiency programs lifted profitability.

What The Results Changed For The Bodycote Debate

The clearest new fact was Bodycote’s H1 2026 report. Revenue moved from £369m in H1 2025 to £381.2m, while net income excluding extra items shifted from £27.7m to £31m and net margin edged from 7.5% to 8.1%. Taken together, those figures supported the optimistic case on profitability, although they did not address longer term reshoring or regulatory worries.

The takeaway is simple. When a thesis depends on better margins, treat net income and net margin as the primary test and track whether each reporting period actually nudges them in the direction the story implied.

What Today's Bodycote Price Already Assumes

Bodycote now trades at £9.19, so anyone buying today is paying a clear premium to where the year began. The bearish analyst Narrative on Simply Wall St still places its Fair Value below that level, framing the move as confidence in execution rather than a simple bargain.

This Narrative argues the key question is whether Bodycote can turn its portfolio shift and efficiency work into margins that justify the higher entry price. A buyer today is effectively assuming those margin gains stick, so how does the risk of weaker legacy markets and bid led growth affect that bet?

"The main thing that has to go right is that Bodycote converts its portfolio pivot toward higher growth, higher margin end markets and Specialist Technologies, together with the Optimise and Perform programs, into durable margin gains that offset variable pay headwinds, ramp-up costs and restructuring complexity across the network. The numbers implied by the current valuation leave limited allowance for ongoing auto and industrial weakness and execution risk around footprint rationalisation and bid activity, so the share price assumes Bodycote delivers on its mix shift, cost savings and capital deployment with little room for disappointment."

Not everyone reads the same price the same way. → See the lower figure this Narrative lands on, and how it gets there

Go Straight To The Source

By the time a rally makes headlines, you are reading about returns someone else has already earned. Why not go straight to the source and look for your own contrarian opportunity? These three companies trade below our estimated value.

• Company 1 - 24% below our estimate - builds and maintains tailored digital platforms and tools that replace manual workflows.
• Company 2 - 33% below our estimate - channels equity and credit into renewable assets and smaller privately held enterprises.
• Company 3 - 29% below our estimate - runs low cost investment platforms advisers and retail savers use to consolidate portfolios.

That is three of the list. See every one of the 9 solid balance sheet companies →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com